HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point

By Adam J. Fein, Ph.D.The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Once again, the specialty pharmacy market delivered a classic paradox: a sprawling, fragmented landscape of participants paired with highly concentrated economics controlled by a handful of PBM-af

By Drug Channels · May 5, 2026 · via Drug Channels

This is an aggregated industry headline. Read the full story at Drug Channels

Tags
dataformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Data
All Data →
<![CDATA[CAQH Index Finds $20 Billion in Cost Savings Opportunities]]>
DataAJMC ↗
May 1, 2026
DataDrug Channels ↗
By Adam J. Fein, Ph.D.Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty …
Apr 21, 2026
HPV Vaccine Access: Coverage Success, Uptake Problem
Data
Despite full insurance coverage, HPV vaccination rates plateau, with racial disparities and post-pandemic decl…
Apr 17, 2026